In the next two decades, U.S. rankings of the most common and deadly cancer types will shift, reflecting the influence of screening programs and advancements in treatment. Lola Rahib, PhD, Director of Scientific and Clinical Affairs at Cancer Commons, led this research, which appears today in JAMA Network Open. The projections were prepared in collaboration with the Pancreatic Cancer Action Network (PanCAN) and The… Read more »
Cancer Commons founder Marty Tenenbaum, PhD, will join other leading innovators and experts next week as a panelist at the 2021 virtual Precision Medicine World Conference (PMWC). This year’s theme is “21st Century Precision Medicine in the Age of COVID-19.” On Monday, Jan 25, at 1pm PST, Marty will engage with other distinguished panelists in an exploration of how to make clinical trials more accessible… Read more »
Despite 2020 creating some of the most difficult circumstances of our lifetimes, it was a year of progress for Cancer Commons. Cancer Commons’ Model Validated Cancer Commons helps patients and their physicians collectively explore the latest and best treatment options far more efficiently than they can as individuals, often via a “molecular tumor board” model that precisely matches patients to personalized options. We recently… Read more »
This month, Cancer Commons earned the 2020 Platinum Seal of Transparency from GuideStar, a database that helps the public evaluate the performance of all nonprofits in the U.S. The Platinum Seal of Transparency is the highest level of recognition offered by GuideStar. To reach the Platinum level, Cancer Commons added extensive information to our profile on GuideStar: basic contact and organizational information; in-depth financial… Read more »
A new article published by Lets Win! Pancreatic Cancer highlights our virtual tumor boards, which provide “a highly customized experience, connecting patients with our collaborative network of nurse navigators, PhD scientists, and national experts.” This free service helps people find their best-possible treatment options. The piece features insights from Lola Rahib, PhD, our Director of Scientific and Clinical Affairs, and Shaalan Beg, MD, a member of… Read more »
A new article published in J. The Jewish News of Northern California tells the tale of our founder, Marty Tenenbaum, PhD, and how his own experience with metastatic melanoma inspired him to create Cancer Commons: “Not only did I have a disease which was ‘unsurvivable’ at the time, but then I bet my life on a clinical trial on that disease which failed. That’s enough to give… Read more »
In a new piece for Oncology Nurse Advisor, our Nurse Navigator Leslie Jared, RN, MSN, and Executive Director Erika Vial Monteverdi highlight Cancer Commons as the best place for patients to go “when it seems there is nowhere to turn.” They describe how we help patients and caregivers navigate and explore treatment options for the toughest cancer cases. Leslie and Erika presented the topics covered… Read more »
In a new guest post on the Amazon Web Services (AWS) Blog, our Executive Director Erika Vial Monteverdi highlights how we apply AWS. Cancer Commons learns from the experiences and outcomes of all patients we serve. This process requires sophisticated computing and analysis of large datasets, and AWS is an integral component of our system: Read the post.
“We need to break down the barriers between health institutions to allow patients and their trusted clinicians to access global data about individual patient treatment decisions and outcomes.” … A new article written by lymphoma patient Brad Power outlines why the underlying philosophy that drives our work here at Cancer Commons is so important for ensuring that patients receive the care they need. Brad… Read more »
By 2040, we will likely see notable changes in which cancer types are most common and which are most deadly, highlighting the influence of cancer screening programs. Our Director of Scientific and Clinical Affairs, Lola Rahib, PhD, led this research, which was presented at the American Society of Clinical Oncology (ASCO)’s virtual 2020 meeting. These projections, prepared in collaboration with MD Anderson Cancer Center… Read more »
